Springer Nature
Browse
12931_2020_1339_MOESM3_ESM.docx (465.36 kB)

Additional file 3 of A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

Download (465.36 kB)
journal contribution
posted on 2020-03-27, 04:19 authored by Toby M. Maher, Juliet K. Simpson, Joanna C. Porter, Frederick J. Wilson, Robert Chan, Rhena Eames, Yi Cui, Sarah Siederer, Simon Parry, Julia Kenny, Robert J. Slack, Jagdeep Sahota, Lyn Paul, Peter Saunders, Philip L. Molyneaux, Pauline T. Lukey, Gaia Rizzo, Graham E. Searle, Richard P. Marshall, Azeem Saleem, Arthur R. Kang’ombe, David Fairman, William A. Fahy, Mitra Vahdati-Bolouri
Additional file 3: Uncorrected and air-corrected Standardised Uptake Values (SUV); Figure S2a. Summary of adjusted medians of uncorrected SUV (g/mL) of [18F]FB-A20FMDV2 and individual patient profiles; Figure S2b. Summary of adjusted medians of air-corrected SUV (g/mL) of [18F]FB-A20FMDV2 and individual patient profiles

Funding

GlaxoSmithKline

History

Usage metrics

    Respiratory Research

    Categories

    Keywords

    Alpha-v beta-6αvβ6IntegrinIdiopathic pulmonary fibrosisIPF, positron emission tomographyPET[18F]FB-A20FMDV2, target engagement

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC